CTRI/2022/02/039940
Not yet recruiting
Phase 2
A randomized clinical trial to compare the efficacy of rohitakaabhaya kwatha and patolakaturohinyadi kwatha along with diet recommendations in the management of yakrudalyudara(non alcoholic fatty liver disease)
All India Institute Ayurveda0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
- Sponsor
- All India Institute Ayurveda
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Non\-alcoholic fatty liver disease patient, diagnosed by abdomen ultrasonic examination (grade I and II)
- •2\.NAFLD confirmed by USG with or without having symptoms like fatigue, mild discomfort in the upper quadrant of abdomen
Exclusion Criteria
- •1\.Pregnancy and weak patients
- •2\.Any dysfunction of liver besides non\-alcoholic fatty liver disease like hepatitis, liver cirrhosis
- •3\.Liver Transplantation or Any other Condition Interfering with the result of the treatment.
- •4\.Metabolic syndromes such as Type I and II diabetes mellitus, hypertension, thyroid dysfunctions
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 3
Effect of Apatyakara ghrutha and Baladi Yapana basti in oligoasthenoteratozoospermiaCTRI/2024/06/069063ational Institute Of Ayurveda
Completed
Phase 2
The effect of cognitive- behavioural therapy on drug use control and treatment among addicted femaleAddiction.Mental and behavioural disorders due to psychoactive substance useIRCT2015060621684N2Vice Chancellor for Research, Shiraz University of Medical Sciences40
Completed
Phase 4
Intravenous midazolam-droperidol (combination), droperidol (only) or olanzapine (only) for the acutely agitated patient:A multi-centre, randomised, double-blind, controlled, clinical trialACTRN12614000980639Austin Hospital342
Completed
Phase 4
Topical alkane vapocoolant spray versus subcutaneous lignocaine injection for reducing the pain of intravenous cannulation: a randomised, controlled, clinical trialACTRN12608000414314Austin Health220
Completed
Not Applicable
EMLA versus N2O for analgesia during intravenous cannulation of children in the emergency departmentPainAnaesthesiology - AnaestheticsACTRN12606000121561orthern Hospital, VIC100